Wolverine Trading, LLC Provention Bio, Inc. Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $150,750 - $544,725	22,500 New	22,500 $545,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $51,107 - $83,738	14,900 Added 51.74%	43,700 $194,000
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $105,120 - $210,240	28,800 New	28,800 $113,000
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $63,240 - $146,568	-18,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $103,974 - $137,454	18,600 New	18,600 $107,000
Q3 2021 Nov 12, 2021	SELL	$5.66 - $8.33 $77,542 - $114,121	-13,700 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$6.71 - $11.04 $91,927 - $151,248	13,700 New	13,700 $116,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.